CHRONSEAL Trademark

Trademark Overview

On Monday, February 26, 2007, a trademark application was filed for CHRONSEAL with the United States Patent and Trademark Office. The USPTO has given the CHRONSEAL trademark a serial number of 77116028. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 25, 2011. This trademark is owned by Tripep AB. The CHRONSEAL trademark is filed in the Pharmaceutical Products category with the following description:

Topical wound healing medicament containing a recombinant skin growth factor protein for treatment purposes
chronseal

General Information

Serial Number77116028
Word MarkCHRONSEAL
Filing DateMonday, February 26, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 25, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2008

Trademark Statements

Goods and ServicesTopical wound healing medicament containing a recombinant skin growth factor protein for treatment purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 1, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKRINGLE PHARMA EUROPE AB
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressHUDDINGE SE141 57
SE
Party NameKRINGLE PHARMA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressTOYONAKA, OSAKA 5600082
JP
Party NameTripep AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE-141 57 Huddinge
SE
Party NameTripep AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE-141 57 Huddinge
SE

Trademark Events

Event DateEvent Description
Monday, April 25, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 25, 2011ABANDONMENT - NO USE STATEMENT FILED
Friday, October 1, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 30, 2010EXTENSION 5 GRANTED
Thursday, September 23, 2010EXTENSION 5 FILED
Thursday, September 23, 2010TEAS EXTENSION RECEIVED
Tuesday, March 9, 2010EXTENSION 4 GRANTED
Thursday, March 4, 2010EXTENSION 4 FILED
Thursday, March 4, 2010TEAS EXTENSION RECEIVED
Wednesday, September 30, 2009EXTENSION 3 GRANTED
Monday, September 21, 2009EXTENSION 3 FILED
Monday, September 21, 2009TEAS EXTENSION RECEIVED
Wednesday, April 1, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, March 27, 2009EXTENSION 2 GRANTED
Wednesday, March 25, 2009EXTENSION 2 FILED
Wednesday, March 25, 2009TEAS EXTENSION RECEIVED
Wednesday, March 18, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, September 26, 2008EXTENSION 1 GRANTED
Wednesday, September 24, 2008EXTENSION 1 FILED
Friday, September 26, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 24, 2008TEAS EXTENSION RECEIVED
Tuesday, March 25, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 1, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2007NOTICE OF PUBLICATION
Wednesday, November 28, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 28, 2007ASSIGNED TO LIE
Wednesday, October 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 22, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 22, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 22, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 23, 2007NON-FINAL ACTION E-MAILED
Monday, April 23, 2007NON-FINAL ACTION WRITTEN
Monday, April 16, 2007ASSIGNED TO EXAMINER
Thursday, March 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

chronseal factor growth protein treatment purposes skin recombinant wound healing medicament